SynBioBeta Speaker

Elisabeth Brier

Forbes

Deputy Editor

Elisabeth Brier is a Deputy Editor at Forbes, where she leads editorial strategy and operations for some of the publication’s most prominent franchises, including the AI 50, Midas List, and Next Billion Dollar Startups. Based in Los Angeles, she focuses on the intersection of artificial intelligence, venture capital, and sustainability, shaping narratives around the world’s most influential founders, investors, and technologies. She also leads Forbes’ major climate editorial initiatives, including the Sustainability Leaders list and summit, bringing together global leaders across climate and frontier innovation.

Sessions Featuring

Elisabeth

This Year

Main Stage Panel

•

11:05 AM

-

11:30 AM

Tools & Tech

From AI protein design to real-world commercial impact: powering the next wave of everyday products

For more than a century, everyday products - from detergents and shampoos to textiles and packaging - have relied on petrochemicals and harsh industrial processes. Today, AI-driven protein design is opening a radically different path: creating custom enzymes and biomolecules that outperform traditional chemistry while reducing environmental impact. This session explores how advances in computational protein design and machine learning enable the rational creation of enzymes tailored for home care, personal care, and next-generation materials—moving beyond incremental discovery to purpose-built performance under real industrial conditions. Critically, this highlights how AI-driven design is being translated into commercially deployed products at scale with partners and customers.

Featuring

Neil Parry

Unilever

R&D Dir. Biotech

Building biotech into global consumer brands

Alexandre Zanghellini

Arzeda

Co-founder & CEO

David Baker protégé redesigning industry with proteins

Paul Bielewicz

W. L. Gore & Associates

Dir. of Innov. & Venture Dev.

Guus Gerritsen

MANE Ingredients USA

Managing Director

Elisabeth Brier

Forbes

Deputy Editor

Main Stage Panel

•

11:05 AM

-

11:30 AM

Tools & Tech

From AI protein design to real-world commercial impact: powering the next wave of everyday products

For more than a century, everyday products - from detergents and shampoos to textiles and packaging - have relied on petrochemicals and harsh industrial processes. Today, AI-driven protein design is opening a radically different path: creating custom enzymes and biomolecules that outperform traditional chemistry while reducing environmental impact. This session explores how advances in computational protein design and machine learning enable the rational creation of enzymes tailored for home care, personal care, and next-generation materials—moving beyond incremental discovery to purpose-built performance under real industrial conditions. Critically, this highlights how AI-driven design is being translated into commercially deployed products at scale with partners and customers.

Featuring

Neil Parry

Unilever

R&D Dir. Biotech

Building biotech into global consumer brands

Alexandre Zanghellini

Arzeda

Co-founder & CEO

David Baker protégé redesigning industry with proteins

Paul Bielewicz

W. L. Gore & Associates

Dir. of Innov. & Venture Dev.

Guus Gerritsen

MANE Ingredients USA

Managing Director

Elisabeth Brier

Forbes

Deputy Editor

Previous Speakers Include